DEFINITIVE PROXY

Company

PharmaCyte Biotech, Inc.

Filed

July 31, 2023

Period of Report

August 31, 2023

Accession Number

0001683168-23-005167

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →